People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Pharmaceuticals, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ADARx Pharmaceuticals, Inc. | — | Pharmaceuticals | Series D+ | $352.5M | $2.8B | 2020 |
| BlossomHill Therapeutics, Inc. | — | Pharmaceuticals | Series C | $245.8M | $452.7M | 2023 |
| Avedro Inc | — | Other Health Care | Series C | $158.4M | $571.6M | 2018 |
| Perfuse Therapeutics, Inc. | — | Biotechnology | Series A | $11.0M | $319.6M | 2020 |
Hongbo Lu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hongbo Lu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 2 | 24 |
| Garheng Kong | 1 | 16 |
| BIHUA CHEN | 1 | 14 |
| Jonathan Silverstein | 1 | 10 |
| Chau Khuong | 1 | 9 |
| Simeon George | 1 | 8 |
| Judith Li | 1 | 8 |
| Erez Chimovits | 1 | 7 |
| Chen Yu | 1 | 7 |
| Reza Zadno | 1 | 7 |
| Doug Cole | 1 | 6 |
| Philip J. Ferneau | 1 | 6 |
| Christy Shaffer | 1 | 6 |
| George Lee | 1 | 6 |
| Gilbert H. Kliman | 1 | 5 |
| Sheila Gujrathi | 1 | 5 |
| Anthony J. Natale | 1 | 5 |
| Joseph Mandato | 1 | 5 |
| Lorence Kim | 1 | 5 |
| Yishan Li | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.